- Home
- ORIS vs TTNP Comparison
ORIS vs TTNP Comparison
Compare ORIS & TTNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIS
- TTNP
- Stock Information
- Founded
- ORIS 2014
- TTNP 1991
- Country
- ORIS China
- TTNP United States
- Employees
- ORIS N/A
- TTNP N/A
- Industry
- ORIS Farming/Seeds/Milling
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ORIS Consumer Staples
- TTNP Health Care
- Exchange
- ORIS Nasdaq
- TTNP Nasdaq
- Market Cap
- ORIS 5.3M
- TTNP 5.4M
- IPO Year
- ORIS 2024
- TTNP 1996
- Fundamental
- Price
- ORIS $0.11
- TTNP $4.23
- Analyst Decision
- ORIS
- TTNP
- Analyst Count
- ORIS 0
- TTNP 0
- Target Price
- ORIS N/A
- TTNP N/A
- AVG Volume (30 Days)
- ORIS 63.9M
- TTNP 92.5K
- Earning Date
- ORIS 01-01-0001
- TTNP 08-14-2025
- Dividend Yield
- ORIS N/A
- TTNP N/A
- EPS Growth
- ORIS N/A
- TTNP N/A
- EPS
- ORIS 0.17
- TTNP N/A
- Revenue
- ORIS $15,014,000.00
- TTNP N/A
- Revenue This Year
- ORIS N/A
- TTNP N/A
- Revenue Next Year
- ORIS N/A
- TTNP N/A
- P/E Ratio
- ORIS $0.68
- TTNP N/A
- Revenue Growth
- ORIS N/A
- TTNP N/A
- 52 Week Low
- ORIS $0.08
- TTNP $3.03
- 52 Week High
- ORIS $56.01
- TTNP $6.43
- Technical
- Relative Strength Index (RSI)
- ORIS 33.79
- TTNP 45.73
- Support Level
- ORIS $0.11
- TTNP $3.58
- Resistance Level
- ORIS $0.12
- TTNP $4.45
- Average True Range (ATR)
- ORIS 0.01
- TTNP 0.37
- MACD
- ORIS 0.02
- TTNP -0.08
- Stochastic Oscillator
- ORIS 47.00
- TTNP 36.93
About ORIS Oriental Rise Holdings Limited Ordinary Shares
Oriental Rise Holdings Ltd is an integrated supplier of tea products in China. It is principally engaged in the business of planting, cultivating, processing, and selling processed tea. The company currently produces and sells three categories of products: roughly processed white tea, roughly processed black tea, and refined tea. The company's business operations are vertically integrated, covering cultivation, processing of tea leaves, and the sale of tea products to tea business operators and end-user retail customers. Geographically, the company generates all of its revenue from its business in the People's Republic of China (the PRC).
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.